Moore, A. S., Faisal, A., Mak, G. W. Y., Miraki-Moud, F., Bavetsias, V., Valenti, M., . . . Linardopoulos, S. (2020). Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736. Blood Adv.
Παραπομπή Chicago StyleMoore, Andrew S., et al. "Quizartinib-resistant FLT3-ITD Acute Myeloid Leukemia Cells Are Sensitive to the FLT3-Aurora Kinase Inhibitor CCT241736." Blood Adv 2020.
Παραπομπή MLAMoore, Andrew S., et al. "Quizartinib-resistant FLT3-ITD Acute Myeloid Leukemia Cells Are Sensitive to the FLT3-Aurora Kinase Inhibitor CCT241736." Blood Adv 2020.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.